2-diphenylmethylpiperidine has been researched along with Serotonin Syndrome in 1 studies
*Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angerer, V; Auwärter, V; Hermanns-Clausen, M; Just, S; Kithinji, J; Liebetrau, G; Müller, D; Neurath, H | 1 |
1 other study(ies) available for 2-diphenylmethylpiperidine and Serotonin Syndrome
| Article | Year |
|---|---|
[Desoxypipradrol - a new (already well known) designer drug].
Topics: Adolescent; Adult; Designer Drugs; Diagnosis, Differential; Female; Humans; Illicit Drugs; Male; Piperidines; Psychotropic Drugs; Rhabdomyolysis; Serotonin Syndrome; Young Adult | 2016 |